Novartis | Resultat Før Skat

Name: Novartis | Resultat Før Skat
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

	Pre Tax Profit		Dato
Abbvie ABBV:US	$ 5913M	192M	2020-12
Amgen AMGN:US	$ 2634M	338M	2020-12
Aphria Inc APH:CN	C$ -139077000	135.29M	2020-12
Astrazeneca AZN:US	$ 1579M	101M	2020-12
AstraZeneca AZN:LN	1559M	81M	2020-12
Bristol Myers Squibb BMY:US	$ 3941M	572M	2020-12
Catalent CTLT:US	$ 149.6M	46.7M	2020-12
Eli Lilly And LLY:US	$ 2932.6M	1267.5M	2020-12
Endo International Ordinary Shares ENDP:US	$ 190.2M	57.71M	2020-12
Gilead Sciences GILD:US	$ 3271M	26M	2020-12
GlaxoSmithKline GSK:LN	1578M	613M	2020-12
Glaxosmithkline GSK:US	$ 2085.11M	1115.75M	2020-12
Horizon Pharma HZNP:US	$ 360.08M	41.25M	2020-12
Johnson & Johnson JNJ:US	$ 5601M	1645M	2020-12
Lannett LCI:US	$ 2.91M	1.02M	2020-12
Merk MRK:US	$ 3957M	1246M	2020-12
Novartis NOVN:VX	SF 3509M	618M	2020-12
Pacira Pharmaceuticals PCRX:US	$ 39.05M	8.56M	2020-12
Pfizer PFE:US	$ 2665M	2020M	2020-12
Phibro Animal Health PAHC:US	$ 19.41M	3.81M	2020-12
Prestige Brands PBH:US	$ 53.68M	1.78M	2020-12
Sanofi SAN:FP	€ 1962M	997M	2020-12
Supernus Pharmaceuticals SUPN:US	$ 39.69M	13.02M	2020-12
Teva Pharmaceutical Industries TEVA:US	$ 905M	262M	2020-12
Zoetis ZTS:US	$ 505M	150M	2020-12

Novartis Resultat Før Skat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2021.